1. Home
  2. TXG vs G Comparison

TXG vs G Comparison

Compare TXG & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$48.21

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$35.17

Market Cap

5.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
G
Founded
2012
1997
Country
United States
Bermuda
Employees
N/A
140000
Industry
Biotechnology: Laboratory Analytical Instruments
Professional Services
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.4B
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
TXG
G
Price
$48.21
$35.17
Analyst Decision
Hold
Buy
Analyst Count
15
6
Target Price
$20.25
$49.50
AVG Volume (30 Days)
2.8M
2.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
2.21%
EPS Growth
76.97
9.82
EPS
N/A
0.86
Revenue
$245,893,000.00
$2,279,438,000.00
Revenue This Year
N/A
$9.20
Revenue Next Year
$7.33
$7.27
P/E Ratio
N/A
$41.19
Revenue Growth
68.06
N/A
52 Week Low
$11.17
$26.85
52 Week High
$49.84
$48.64

Technical Indicators

Market Signals
Indicator
TXG
G
Relative Strength Index (RSI) 61.65 67.18
Support Level $16.11 $34.36
Resistance Level N/A $38.03
Average True Range (ATR) 2.89 1.18
MACD -0.23 0.69
Stochastic Oscillator 60.79 76.77

Price Performance

Historical Comparison
TXG
G

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About G Genpact Limited

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.

Share on Social Networks: